Testicular cancer differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 9: | Line 9: | ||
{| | {| | ||
|- style="background: #4479BA; color: #FFFFFF; text-align: center;" | |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | ||
! rowspan=" | ! rowspan="3" colspan="2" |Diseases | ||
| style="background: #4479BA; color: #FFFFFF; text-align: center;" rowspan="1" colspan=" | ! rowspan="3" |Unilateral/Bilateral | ||
! | ! rowspan="3" |History | ||
! rowspan="3" |Metastasis | |||
! rowspan="3" |Genetics | |||
| style="background: #4479BA; color: #FFFFFF; text-align: center;" rowspan="1" colspan="2" |'''Clinical manifestations''' | |||
! rowspan="2" colspan="2" |Para-clinical findings | |||
|- | |- | ||
| style="background: #4479BA; color: #FFFFFF; text-align: center;" rowspan="2 | | style="background: #4479BA; color: #FFFFFF; text-align: center;" rowspan="2" |'''Symptoms''' | ||
! | ! rowspan="2" |Physical examination | ||
|- | |- | ||
! | !Lab Findings | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging | |||
|- | |- | ||
| rowspan="5" |Germ Cell | | rowspan="5" |Germ Cell | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Seminoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Seminoma | ||
| | |||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 49: | Line 34: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Embryonal carcinoma | ||
| | |||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 64: | Line 44: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Yolk sac tumor | ||
| | |||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 79: | Line 54: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Teratoma | ||
| | |||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 94: | Line 64: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Choriocarcinoma | ||
| | |||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 111: | Line 76: | ||
! | ! | ||
!Diseases | !Diseases | ||
! | !Unilateral/Bilateral | ||
! | !History | ||
! | !Metastasis | ||
! | !Genetics | ||
! rowspan="1" colspan="1" |Physical exam | !Symptoms | ||
! rowspan="1" colspan="1" |Physical exam | |||
!Lab Findings | |||
!Imaging | |||
!Lab | |||
!Imaging | |||
|- | |- | ||
| rowspan=" | | rowspan="3" |Non germ cell | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Leydig cell tumor | ||
| | |||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 141: | Line 96: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Sertoli cell tumor | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 186: | Line 106: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Testicular lymphoma | ||
| | |||
| | |||
| | |||
| | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 201: | Line 116: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| | | colspan="2" |Carcinoma in situ of the testicle | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- style="background: #4479BA; color: #FFFFFF; text-align: center;" | |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | ||
|} | |} |
Revision as of 20:03, 22 January 2019
Testicular cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Testicular cancer differential diagnosis On the Web |
American Roentgen Ray Society Images of Testicular cancer differential diagnosis |
Risk calculators and risk factors for Testicular cancer differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]
Overview
Testicular cancer must be differentiated from epididymitis, hematocele, hydrocele, spermatocele, granulomatous orchitis, and varicocele.
Differentiating Testicular cancer from other Diseases
Testicular cancer must be differentiated from:
Diseases | Unilateral/Bilateral | History | Metastasis | Genetics | Clinical manifestations | Para-clinical findings | |||
---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||
Lab Findings | Imaging | ||||||||
Germ Cell | Seminoma | ||||||||
Embryonal carcinoma | |||||||||
Yolk sac tumor | |||||||||
Teratoma | |||||||||
Choriocarcinoma | |||||||||
Diseases | Unilateral/Bilateral | History | Metastasis | Genetics | Symptoms | Physical exam | Lab Findings | Imaging | |
Non germ cell | Leydig cell tumor | ||||||||
Sertoli cell tumor | |||||||||
Testicular lymphoma | |||||||||
Carcinoma in situ of the testicle |